Connect Biopharma closes $115m in Series C round led by RA Capital

Connect Biopharma closes $115m in Series C round led by RA Capital

Suzhou

US and China-based clinical-stage biopharmaceutical firm Connect Biopharma on Monday announced the completion of a $115-million Series C round of financing led by new investor RA Capital Management, a Boston-based multi-stage investment company.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter